Cite
MLA Citation
M. Jacquemin et al.. “The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders.” Journal of thrombosis and haemostasis, vol. 13, n.d., pp. 2087–2092. http://access.bl.uk/ark:/81055/vdc_100027755730.0x00002a